EditorialJournal of Pharmacology and PharmacotherapeuticsVol. 3 | Issue 2 | 2012 | pp. 95–97Open access
Clinical trial ethics in India: One step forward, two steps back
- 1*
- 1 Researcher, Bioethics and Global Health, Pune, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Anant Bhan
Researcher, Bioethics and Global Health, Pune, India.
Email: anantbhan@gmail.com
Copyright: © 2012 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2012
How to cite
Bhan, A. (2012). Clinical trial ethics in India: One step forward, two steps back. Journal of Pharmacology and Pharmacotherapeutics, 3(2), 95–97. https://doi.org/10.4103/0976-500X.95501
Abstract
The recent reporting of controversial drug trials being conducted by doctors of the government medical college and private practitioners on ‘mentally challenged’ patients in Indore has caused uproar.[5] It was alleged that for more than two years, from 2008 to 2010, trials were conducted flouting ethics guidelines. The Madhya Pradesh government levied a fine of Rs 5000 each on the doctors involved, and this was seen widely as being paltry and insufficient punishment.[6] As details emerged, questions were raised about the role of independent or commercial (as compared to institutional) ethics committees, improper documentation of consent, vulnerability of research participants as well as the thorny issue of private practice (and in this case, research in private clinics) by government doctors.
Keywords
Subject
Article metadata
| Title | Clinical trial ethics in India: One step forward, two steps back |
|---|---|
| Authors | Anant Bhan |
| Affiliations | Researcher, Bioethics and Global Health, Pune, India. |
| Corresponding author | anantbhan@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 3, Issue 2 (2012) |
Also in this issue
- Pharmacotherapy for multidrug resistant tuberculosispp. 98–104
- A review of antihistamines used during pregnancypp. 105–108
- Ulipristal acetate, a progesterone receptor modulator for emergency contraceptionpp. 109–111
- Epilepsy: Novel therapeutic targetspp. 112–117
- Vitamin D: The “sunshine” vitaminpp. 118–126
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026